Dronapushpi (Leucas cephalotes)

Dronapushpi (Leucas cephalotes) is an Ayurvedic herb whose bioactive flavonoids, including luteolin and apigenin, exert antioxidant and anti-inflammatory effects by scavenging free radicals and suppressing pro-inflammatory mediators. Its anti-filarial activity has been demonstrated in vitro against Setaria cervi adult worms and microfilaria, positioning it as a candidate for further parasitic disease research.

Origin & History

Dronapushpi (Leucas cephalotes) is an annual herbaceous plant from the Lamiaceae family native to India and other parts of Asia, commonly found in wastelands and grasslands. The whole plant (panchanga), including leaves, stems, flowers, and seeds, is used medicinally, typically as powdered plant material or methanol extracts.

Historical & Cultural Context

In Ayurveda, Dronapushpi has been used for centuries to balance Kapha and Vata doshas, treating infections, inflammation, fever, respiratory issues, diabetes, scabies, and filariasis. The herb is characterized by its Katu Rasa (pungent taste), Ushna Virya (hot potency), and has been applied as an anthelmintic, antiseptic, emmenagogue, and diaphoretic.

Health Benefits

• Antioxidant activity demonstrated through DPPH scavenging in preclinical studies (animal/in vitro evidence only)
• Anti-inflammatory effects attributed to flavonoid content (preliminary evidence from animal models)
• Anti-filarial properties shown against adult worms and microfilaria in laboratory studies (no human trials)
• Traditional antimicrobial and antidiabetic applications supported by in vitro research only
• Hepatoprotective potential observed in animal models (no clinical validation)

How It Works

Flavonoids in Leucas cephalotes, particularly luteolin and apigenin, inhibit cyclooxygenase (COX) and lipoxygenase (LOX) enzymes, reducing synthesis of prostaglandins and leukotrienes responsible for the inflammatory cascade. Antioxidant activity is mediated through direct hydrogen atom donation to DPPH and other reactive oxygen species, as well as upregulation of endogenous antioxidant enzymes such as superoxide dismutase and catalase in preclinical models. Anti-filarial effects are hypothesized to involve disruption of neuromuscular function in nematodes, though the precise receptor targets remain under investigation.

Scientific Research

No human clinical trials, RCTs, or meta-analyses have been conducted on Dronapushpi. All available evidence is limited to preclinical studies including in vitro assays and animal models investigating antioxidant, anti-inflammatory, and anti-filarial activities.

Clinical Summary

Current evidence for Dronapushpi is limited entirely to in vitro cell-based assays and animal model studies; no human clinical trials have been published as of the available literature. DPPH radical scavenging studies demonstrated concentration-dependent antioxidant activity, with IC50 values reported in the range of 40–80 µg/mL in ethanolic leaf extracts across multiple laboratory experiments. Anti-filarial studies conducted against Setaria cervi showed motility inhibition and worm death at extract concentrations between 1–4 mg/mL, comparable to reference anthelmintics in controlled laboratory conditions. The overall evidence base is preliminary, and no efficacy or safety conclusions can be extrapolated to human therapeutic use without controlled clinical trials.

Nutritional Profile

Dronapushpi (Leucas cephalotes) is not typically consumed as a food for macronutrient value but is utilized as a medicinal herb in Ayurveda. Its nutritional and phytochemical profile is characterized primarily by bioactive compounds rather than caloric or macronutrient content. Key constituents include: **Flavonoids:** Apigenin, luteolin, and their glycosides (estimated 1.5–3.5% w/w of dried aerial parts), which are responsible for much of the reported antioxidant and anti-inflammatory activity. **Terpenoids/Sterols:** β-sitosterol, oleanolic acid, and ursolic acid have been identified in the whole plant extract; concentrations vary by plant part but are typically in the range of 0.2–0.8% w/w in dried leaf material. **Alkaloids:** Minor alkaloid content (~0.1–0.4% w/w) detected in ethanolic extracts of leaves and stems; specific alkaloid identities are not fully characterized. **Phenolic acids:** Gallic acid, caffeic acid, and chlorogenic acid detected via HPLC in methanolic extracts, contributing to total phenolic content of approximately 25–45 mg gallic acid equivalents (GAE) per gram of dried extract. **Essential oil:** Aerial parts yield 0.2–0.5% (v/w) essential oil containing α-thujone, caryophyllene, germacrene-D, and β-pinene as major volatile constituents. **Tannins:** Present at approximately 2–5% w/w in dried leaf tissue, contributing to astringent and antimicrobial properties. **Saponins:** Moderate saponin content identified in root and aerial parts. **Minerals (from ash analysis of dried herb):** Iron (Fe) ~8–15 mg/100 g, calcium (Ca) ~200–350 mg/100 g, potassium (K) ~150–300 mg/100 g, magnesium (Mg) ~80–150 mg/100 g, and zinc (Zn) ~2–5 mg/100 g (values approximate, based on limited elemental analyses of wild-harvested specimens). **Crude fiber:** ~12–18% of dry weight in aerial parts. **Crude protein:** ~8–12% of dry weight. **Vitamins:** Ascorbic acid (vitamin C) reported at approximately 15–30 mg/100 g fresh leaf weight in limited analyses; no reliable data on B-vitamins or fat-soluble vitamins. **Leucasin:** A nicotinyl glycoside relatively unique to Leucas species, detected in small quantities; pharmacological significance is under investigation. **Bioavailability notes:** The flavonoids (apigenin, luteolin) are present largely as glycosides, which require intestinal hydrolysis for absorption; oral bioavailability of aglycone forms is generally low (estimated 2–10%) due to rapid phase II metabolism (glucuronidation/sulfation). Tannin content may further reduce bioavailability of co-administered minerals (particularly iron and calcium) through chelation. Traditional Ayurvedic preparations as svarasa (fresh juice) or kwatha (decoction) may partially address solubility limitations of lipophilic terpenoids. The essential oil components are relatively volatile and may be lost during prolonged boiling. No standardized extract with guaranteed phytochemical concentrations is commercially established; reported values are derived from limited analytical studies and may vary significantly with geographic origin, harvest season, plant part, and extraction method.

Preparation & Dosage

No clinically studied dosage ranges are available due to lack of human trials. Traditional Ayurvedic recommendations suggest 3-6 grams per day of powdered whole plant for adults, often as decoction or churna (powder). Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Ashwagandha, Tulsi, Guduchi, Turmeric, Triphala

Safety & Interactions

No formal human safety trials exist for Dronapushpi, making it impossible to establish a confirmed adverse effect profile or safe dosage range for supplemental use. Traditional Ayurvedic texts classify it as generally safe at dietary exposure levels, but high-dose concentrated extracts have not been evaluated for hepatotoxicity or nephrotoxicity in long-term animal studies. Potential interactions with anticoagulants and anti-inflammatory drugs (NSAIDs) are theoretically possible given its COX-inhibiting flavonoid content, though no pharmacokinetic interaction studies have been conducted. Pregnant and breastfeeding individuals should avoid supplemental use due to the complete absence of reproductive safety data.